Download XLS |
2012 | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
| |||||||||||||||
€ million |
Silicones |
Polymers |
Bio- |
Polysilicon |
Siltronic |
Other |
Con- |
Group | |||||||||||||||
| |||||||||||||||||||||||
|
|
|
|
|
|
|
|
| |||||||||||||||
External sales |
1,633.8 |
975.3 |
154.1 |
949.4 |
858.5 |
63.8 |
– |
4,634.9 | |||||||||||||||
Internal sales |
14.2 |
27.8 |
3.5 |
186.4 |
9.4 |
106.1 |
-347.4 |
– | |||||||||||||||
Total sales |
1,648.0 |
1,003.1 |
157.6 |
1,135.8 |
867.9 |
169.9 |
-347.4 |
4,634.9 | |||||||||||||||
|
|
|
|
|
|
|
|
| |||||||||||||||
106.4 |
110.7 |
17.8 |
200.8 |
-92.2 |
-85.4 |
-0.1 |
258.0 | ||||||||||||||||
Depreciation and impairments/appreciation of noncurrent assets |
82.9 |
36.7 |
6.7 |
226.7 |
92.9 |
82.9 |
– |
528.8 | |||||||||||||||
189.3 |
147.4 |
24.5 |
427.5 |
0.7 |
-2.5 |
-0.1 |
786.8 | ||||||||||||||||
|
|
|
|
|
|
|
|
| |||||||||||||||
EBIT includes: |
|
|
|
|
|
|
|
| |||||||||||||||
Result from investments in joint ventures and associates |
-55.9 |
– |
– |
– |
-26.6 |
– |
-0.1 |
-82.6 | |||||||||||||||
Impairment losses |
– |
– |
– |
– |
-2.5 |
– |
– |
-2.5 | |||||||||||||||
Additions to property, plant and equipment1 |
70.9 |
58.8 |
19.3 |
698.1 |
73.3 |
56.9 |
– |
977.3 | |||||||||||||||
Additions to financial assets2 |
87.9 |
– |
– |
– |
29.9 |
0.3 |
– |
118.1 | |||||||||||||||
Asset additions |
158.8 |
58.8 |
19.3 |
698.1 |
103.2 |
57.2 |
– |
1,095.4 | |||||||||||||||
|
|
|
|
|
|
|
|
| |||||||||||||||
Assets (Dec. 31) |
1,180.4 |
483.2 |
107.6 |
2,417.6 |
1,136.6 |
1,270.5 |
-266.0 |
6,329.9 | |||||||||||||||
Liabilities (Dec. 31) |
569.3 |
220.5 |
44.8 |
1,917.6 |
238.2 |
985.0 |
-263.3 |
3,712.1 | |||||||||||||||
Net assets (Dec. 31) |
611.1 |
262.7 |
62.8 |
500.0 |
898.4 |
285.5 |
-2.7 |
2,617.8 | |||||||||||||||
|
|
|
|
|
|
|
|
| |||||||||||||||
Investments in joint ventures and associates included in net assets (Dec. 31) |
19.3 |
– |
– |
– |
22.2 |
– |
-0.5 |
41.0 | |||||||||||||||
Research and development expenses |
31.3 |
13.0 |
6.6 |
12.8 |
67.4 |
48.4 |
-5.0 |
174.5 | |||||||||||||||
Employees (Dec. 31) |
3,960 |
1,365 |
357 |
2,349 |
3,978 |
4,283 |
– |
16,292 | |||||||||||||||
Employees (average) |
3,947 |
1,370 |
349 |
2,325 |
4,351 |
4,321 |
– |
16,663 |
Download XLS |
2011 | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
| |||||||||||||||
€ million |
Silicones |
Polymers |
Bio- |
Polysilicon |
Siltronic |
Other |
Con- |
Group | |||||||||||||||
| |||||||||||||||||||||||
|
|
|
|
|
|
|
|
| |||||||||||||||
External sales |
1,580.2 |
901.4 |
138.9 |
1,234.8 |
985.1 |
69.3 |
– |
4,909.7 | |||||||||||||||
Internal sales |
13.6 |
26.7 |
5.6 |
212.9 |
7.0 |
107.6 |
-373.4 |
– | |||||||||||||||
Total sales |
1,593.8 |
928.1 |
144.5 |
1,447.7 |
992.1 |
176.9 |
-373.4 |
4,909.7 | |||||||||||||||
|
|
|
|
|
|
|
|
| |||||||||||||||
EBIT |
103.3 |
76.2 |
13.3 |
545.6 |
-56.7 |
-78.9 |
0.4 |
603.2 | |||||||||||||||
Depreciation and impairments/appreciation of noncurrent assets |
79.6 |
35.6 |
7.1 |
201.7 |
105.9 |
71.1 |
– |
501.0 | |||||||||||||||
EBITDA |
182.9 |
111.8 |
20.4 |
747.3 |
49.2 |
-7.8 |
0.4 |
1,104.2 | |||||||||||||||
|
|
|
|
|
|
|
|
| |||||||||||||||
EBIT includes: |
|
|
|
|
|
|
|
| |||||||||||||||
Result from investments in joint ventures and associates |
16.7 |
– |
– |
– |
-24.4 |
– |
– |
-7.7 | |||||||||||||||
Impairment losses |
– |
– |
-0.7 |
-25.9 |
-14.8 |
– |
– |
-41.4 | |||||||||||||||
Additions to property, plant and equipment1 |
87.9 |
30.4 |
8.6 |
566.5 |
93.2 |
141.3 |
– |
927.9 | |||||||||||||||
Additions to financial assets2 |
18.4 |
– |
– |
– |
34.9 |
– |
– |
53.3 | |||||||||||||||
Asset additions |
106.3 |
30.4 |
8.6 |
566.5 |
128.1 |
141.3 |
– |
981.2 | |||||||||||||||
|
|
|
|
|
|
|
|
| |||||||||||||||
Assets (Dec. 31) |
1,197.7 |
478.9 |
96.1 |
1,928.7 |
1,190.4 |
1,672.0 |
-326.8 |
6,237.0 | |||||||||||||||
Liabilities (Dec. 31) |
597.9 |
209.1 |
39.8 |
1,796.4 |
317.3 |
965.5 |
-318.7 |
3,607.3 | |||||||||||||||
Net assets (Dec. 31) |
599.8 |
269.8 |
56.3 |
132.3 |
873.1 |
706.5 |
-8.1 |
2,629.7 | |||||||||||||||
|
|
|
|
|
|
|
|
| |||||||||||||||
Investments in joint ventures and associates included in net assets (Dec. 31) |
80.0 |
– |
– |
– |
44.9 |
– |
-0.4 |
124.5 | |||||||||||||||
Research and development expenses |
25.4 |
14.1 |
6.2 |
14.5 |
71.7 |
42.8 |
-1.8 |
172.9 | |||||||||||||||
Employees (Dec. 31) |
3,956 |
1,412 |
354 |
2,251 |
4,974 |
4,221 |
– |
17,168 | |||||||||||||||
Employees (average) |
3,957 |
1,404 |
357 |
2,054 |
5,002 |
4,160 |
– |
16,934 |